| Financial Year |
March 31 2023 |
| Monetary Funds |
324,038,389.63 |
| Held-for-trading Financial Assets |
703,556,180.82 |
| Notes Receivable |
-- |
| Accounts Receivable |
87,199,159.08 |
| Advances to Suppliers |
7,719,590.44 |
| Other Receivables |
282,484.34 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
98,471,474.54 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
62,302,422.40 |
| Total Current Assets |
1,329,991,791.29 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
121,027,310.70 |
| Under-construction Projects |
9,305,861.14 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
12,005,967.70 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
8,096,774.29 |
| Deferred Income Tax Assets |
1,268,102.83 |
| Other Non-Current Assets |
2,696,425.35 |
| Sub-Total of Non-Current Assets |
154,400,442.01 |
| Total Assets |
1,484,392,233.30 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
73,909,266.67 |
| Accounts Payable |
49,180,556.19 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
5,393,819.19 |
| Taxes Payable |
7,089,974.37 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
93,581.48 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
44,953.40 |
| Sub-Total of Current Liabilities |
137,230,029.85 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,109,639.87 |
| Deferred Income Tax Liabilities |
2,323,075.09 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,432,714.96 |
| Total Liabilities |
140,662,744.81 |
| Paid-In Capital(Or Share Stock) |
90,000,000.00 |
| Capital Surplus |
894,589,336.24 |
| Surplus Reserve |
49,619,967.14 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
309,520,185.11 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,343,729,488.49 |
| Owner's Equity（Stockholder's Equity） |
1,343,729,488.49 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,484,392,233.30 |
